BioSpace News Archive

Accomplishments are integral to the aspects of the annual performance review. And here’s how to prepare for review to admit a good performance record in the company.

Tyson served as CEO of Kaiser Permanente since 2013 and spent more than 30 years with the nonprofit healthcare giant.

Announces “Functional to FFPE” Early-Access Grant Program

Secarna Pharmaceuticals, a new breed of biopharmaceutical company focusing on the discovery and development of antisense oligonucleotide therapies to address challenging or previously undruggable targets, announced that the Company has completed a financing round, which was open only to existing investors.

This technology is applicable to both personalized pain treatment and the development of novel pain management therapies, such as non-opioid medications.

Novartis said the acquisition will enable Sandoz to expand its presence in the third-largest worldwide generics marketplace.

The merged company will be led by David Domzalski, current chief executive officer of Foamix. It will be headquartered in New Jersey.

Both DISCOVER 1 and DISCOVER 2 are evaluating Tremfya in adults with active psoriatic arthritis.

In Phase 2b development for the treatment of life-threatening fungal infections

ORYX, a translational medicine company focused on oncolytic virotherapy and cancer vaccines, reported new results on the mode of action of oncolytic virus ParvOryx in human ovarian cancer explants.